Top Markets
Coin of the day
Genenta Science S.p.A. Genenta Science S.p.A.

Genenta Science S.p.A.

GNTA
Rankning i aktier #28058
Genenta Science S.p.A. is an Italian clinical-stage biotechnology firm focused... Genenta Science S.p.A. is an Italian clinical-stage biotechnology firm focused on pioneering hematopoietic stem cell gene therapies to combat solid tumors. Its primary therapeutic candidate, Temferon, is currently undergoing Phase 1/2a clinical evaluation. This innovative therapy is being developed to treat glioblastoma multiforme, specifically targeting patients whose tumors exhibit an unmethylated MGMT gene promoter. Beyond this, Genenta Science is exploring Temferon's potential application in various other solid tumor types, including locally advanced hepatocellular carcinoma and intra-hepatic cholangiocarcinoma. Established in 2014, the company maintains its headquarters in Milan, Italy.
Aktiekurs
$1.51
Senast synkroniserad: 2026-07-31
Marknadsvärde
$28.82M
Förändring (1 dag)
-0.33%
Förändring (1 år)
-57.49%
Land
IT
Handel Genenta Science S.p.A. (GNTA)

Kategori

Historik för aktiesplit för Genenta Science S.p.A. (GNTA)
Aktien Genenta Science S.p.A. (symbol: GNTA) har genomgått totalt 0 aktiesplitar.
Den senaste spliten skedde den Aug 20, 2026.
En GNTA-aktie köpt före Aug 20, 2026 motsvarar nu 0 GNTA-aktier.
Lista över aktiesplitar
År Split Multipel Kumulativ multipel
Inte tillräckligt med data för de angivna datumen.
Aktiesplitar för liknande företag eller konkurrenter
Företag Antal aktiesplitar Kumulativ multipel Land
1 x2
US
0 -
US
0 -
NL
1 x3
AU
0 -
CH